LYMPHOHEMOPOIETIC AND STROMAL CHIMERISM AFTER ALLOGENEIC BMT FOR CHRONIC MYELOGENOUS LEUKEMIA

被引：0
|
作者：
SCHMITZ, N
SCHMIDT, G
SUTTORP, M
JOHANNSON, W
GASSMANN, W
LOFFLER, H
机构：
[1] UNIV KIEL,DEPT MED,D-2300 KIEL 1,FED REP GER
[2] UNIV KIEL,DEPT PEDIAT,D-2300 KIEL 1,FED REP GER
来源：
EXPERIMENTAL HEMATOLOGY | 1988年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：500 / 500
页数：1
相关论文
共 50 条
  • [31] Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: Is there an option to prevent relapse?
    Bader, P
    Beck, J
    Schlegel, PG
    Handgretinger, R
    Niethammer, D
    Klingebiel, T
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (01) : 79 - 81
  • [32] A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase
    Elmaagacli, AH
    Runkel, K
    Steckel, N
    Opalka, B
    Trenschel, R
    Seeber, S
    Schaefer, UW
    Beelen, DW
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (08) : 809 - 815
  • [33] A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase
    AH Elmaagacli
    K Runkel
    N Steckel
    B Opalka
    R Trenschel
    S Seeber
    UW Schaefer
    DW Beelen
    [J]. Bone Marrow Transplantation, 2001, 27 : 809 - 815
  • [34] Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?
    P Bader
    J Beck
    PG Schlegel
    R Handgretinger
    D Niethammer
    T Klingebiel
    [J]. Bone Marrow Transplantation, 1997, 20 : 79 - 81
  • [35] Donor leukocyte infusions for relapsed leukemia after allogeneic BMT
    Mackinnon, S
    [J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 (05) : 461 - 462
  • [36] Testicular relapse of acute promyelocytic leukemia after allogeneic BMT
    Forrest, DL
    Dalal, BI
    Naiman, SC
    Horsman, DE
    Berry, BR
    Parslow, MI
    Singh, CP
    Benny, WB
    Barnett, MJ
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 689 - 690
  • [37] IMMUNOPOTENTIATION WITH UBENIMEX FOR PREVENTION OF LEUKEMIA RELAPSE AFTER ALLOGENEIC BMT
    HIRAOKA, A
    SHIBATA, H
    MASAOKA, T
    [J]. TRANSPLANTATION PROCEEDINGS, 1992, 24 (06) : 3047 - 3048
  • [38] ALLOGENEIC BONE-MARROW TRANSPLANT IN CHRONIC MYELOGENOUS LEUKEMIA
    SPECK, B
    GRATWOHL, A
    NISSEN, C
    OSTERWALDER, B
    MULLER, M
    BANNERT, P
    MULLER, HJ
    JEANNET, M
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 112 (41) : 1419 - 1420
  • [39] ALLOGENEIC MARROW TRANSPLANTATION FOR CHILDREN WITH JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    SANDERS, JE
    BUCKNER, CD
    THOMAS, ED
    FLEISCHER, R
    SULLIVAN, KM
    APPELBAUM, FA
    STORB, R
    [J]. BLOOD, 1988, 71 (04) : 1144 - 1146
  • [40] Allogeneic bone marrow transplantation in children with chronic myelogenous leukemia
    Sharathkumar, A
    Thornley, I
    Saunders, EF
    Calderwood, S
    Freedman, MH
    Doyle, J
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (03) : 215 - 219
12345